Hospira Issues Recall for Particles Found in Vials
Hospira, Inc. recently initiated a voluntary nationwide recall for one lot of 0.25% Bupivacaine HCl Injection, USP (2.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1159-02). The recall was expanded in August to also include a lot of 0.75% Bupivacaine HCl Injection, USP (7.5 mg/mL), 30 mL Single-dose Vial (NDC 0409-1165-02).
About the Bupivacaine HCL Injection Lots Recall
According to the U.S Food and Drug Administration (FDA), the recall was made in response to reports of particulate matter floating or embedded in the drugs glass vials. The FDA recommends that anyone with an existing inventory should immediately stop using the product and return the product to Stericycle.
Description of Recalled Bupivacaine HCL Injection Lots
- The products are packaged 25 units per carton/50 units per case in glass teartop vials.
- The particulate was identified as stainless steel ranging in size from 542 microns to 1700 microns in lot 18-136-DK (0.25% bupivacaine) and as iron oxide with an average size of 2000 microns in lot 23-338-DK (0.75% bupivacaine).
- According to the FDA release, lot 18-136-DK was distributed August 2012 through September 2012 while lot 23-338-DK was distributed between January 2013 and May 2013 to wholesalers/distributors, hospitals and pharmacies.
- According to the National Library of Medicine, presence of foreign particulates may potentially cause thrombophlebitis, bacteremia, sepsis, and/or endocarditis and death may result.
- Signs and symptoms could include redness, pain, swelling at the site, fever, shortness of breath, tachycardia, nausea and vomiting.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.